2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with …

A Pelliccia, S Sharma, S Gati, M Bäck… - European heart …, 2021 - academic.oup.com
or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes

EUGenMed… - European heart …, 2016 - academic.oup.com
In the vast majority of cardiovascular diseases (CVDs), there are well-described differences
between women and men in epidemiology, pathophysiology, clinical manifestations, effects …

[HTML][HTML] HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

SG Priori, AA Wilde, M Horie, Y Cho, ER Behr… - Journal of …, 2014 - Elsevier
This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart …

Linking disease associations with regulatory information in the human genome

MA Schaub, AP Boyle, A Kundaje, S Batzoglou… - Genome …, 2012 - genome.cshlp.org
Genome-wide association studies have been successful in identifying single nucleotide
polymorphisms (SNPs) associated with a large number of phenotypes. However, an …

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of …

GA Dan, A Martinez-Rubio, S Agewall, G Boriani… - Ep …, 2018 - academic.oup.com
NSAT Non-sustained atrial tachycardia NSVT Non-sustained ventricular tachycardia PD
Pharmacodynamic P-GP P-glucoprotein PK Pharmacokinetic PM Pacemaker PVT …

Drug-induced prolongation of the QT interval

DM Roden - New England Journal of Medicine, 2004 - Mass Medical Soc
The single most common cause of the withdrawal or restriction of the use of marketed drugs
has been QT-interval prolongation associated with polymorphic ventricular tachycardia, or …

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

Developed in Collaboration With the European … - Journal of the American …, 2006 - jacc.org
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: A Report of the American College of …

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias

PJ Schwartz, SG Priori, C Spazzolini, AJ Moss… - Circulation, 2001 - Am Heart Assoc
Background—The congenital long-QT syndrome (LQTS) is caused by mutations on several
genes, all of which encode cardiac ion channels. The progressive understanding of the …

[HTML][HTML] Risk stratification in the long-QT syndrome

SG Priori, PJ Schwartz, C Napolitano… - … England Journal of …, 2003 - Mass Medical Soc
Background Mutations in potassium-channel genes KCNQ1 (LQT1 locus) and KCNH2
(LQT2 locus) and the sodium-channel gene SCN5A (LQT3 locus) are the most common …

Task force on sudden cardiac death of the European Society of Cardiology

SG Priori, E Aliot, C Blomstrom-Lundqvist… - European heart …, 2001 - academic.oup.com
The members of the Task Force on Sudden Death dedicate this paper to the memory of our
former friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working …